Banka BioLoo repays NCDs aggregating Rs 4.30 Cr

1 min read     Updated on 26 Jun 2026, 04:12 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Banka BioLoo Ltd has fully repaid 430 secured, unrated, unlisted Non-Convertible Debentures (NCDs) aggregating Rs 4.30 Cr on June 22, 2026. The company received the No Due Certificate from the debenture holder on June 25, 2026, confirming no outstanding amounts against the facility.

powered bylight_fuzz_icon
44016116

*this image is generated using AI for illustrative purposes only.

Banka BioLoo Ltd has fully repaid 430 secured, unrated, unlisted, redeemable, transferable Non-Convertible Debentures (NCDs) aggregating Rs 4.30 Cr on June 22, 2026. The repayment was made at par, with each debenture valued at Rs 1,00,000. The company received the No Due Certificate dated June 24, 2026, from the debenture holder on June 25, 2026, confirming that the facility was fully repaid and no amounts remain outstanding.

Details of the Repayment

The repayment covered the entire principal amount of the NCDs issued by the company. The debentures were unlisted, and therefore, the disclosure requirements under Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, relating to listed non-convertible securities, were not applicable.

Feature Details
Type of Instrument Secured, unrated, unlisted, redeemable, transferable NCDs
Number of NCDs 430
Face Value per NCD Rs 1,00,000
Total Amount Repaid Rs 4.30 Cr
Repayment Date June 22, 2026
No Due Certificate Date June 24, 2026
Certificate Receipt Date June 25, 2026

The intimation regarding this repayment was submitted to the National Stock Exchange of India Ltd. under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Namita Sanjay Banka, Managing Director of Banka BioLoo Limited.

Historical Stock Returns for Banka Bioloo

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-2.07%-0.33%+43.69%+28.52%+41.00%

How will the repayment of Rs 4.30 Cr impact Banka BioLoo's leverage ratios and future borrowing capacity?

Does the company plan to raise fresh capital to fund expansion following this debt clearance?

What are the expected cost savings from reduced interest obligations, and how will they be allocated?

Banka Bioloo lists 9,500 ESOP shares on NSE

1 min read     Updated on 26 Jun 2026, 01:18 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Banka Bioloo Limited announced that the National Stock Exchange of India Limited (NSE) has granted listing and trading approval for 9,500 equity shares allotted under its Employee Stock Option Plan (ESOP). The shares, with a face value of Rs. 10 each, will be available for trading starting June 29, 2026. The company will continue to disclose price-sensitive information via the NSE Electronic Application Processing System (NEAPS) in compliance with SEBI regulations.

powered bylight_fuzz_icon
43962457

*this image is generated using AI for illustrative purposes only.

Banka Bioloo Limited has secured listing and trading approval for 9,500 equity shares allotted under its Employee Stock Option Plan (ESOP). The National Stock Exchange of India Limited (NSE) granted the approval on June 25, 2026, with the effective date for dealings set as June 29, 2026. This development increases the number of equity shares available for trading under the BANKA symbol on the exchange.

The allotment consists of equity shares of Rs. 10 each, which have been admitted to dealings on the NSE. The distinctive numbers for these securities range from 10922433 to 10931932. The company submitted the application for this listing of further issue pursuant to the ESOP allotment made by the company.

The following table details the securities listed:

Sr. No. Security Description Symbol Series No. of securities Distinctive Numbers
1. Equity shares of Rs. 10/- each allotted under ESOP. BANKA EQ 9500 10922433 to 10931932

The company is required to provide all critical and price-sensitive information through the NSE Electronic Application Processing System (NEAPS). This online filing facility ensures quicker and efficient processing of submissions under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Manjula Chunduru, Company Secretary & Compliance Officer of Banka Bioloo Limited, confirmed the receipt of the approval letter from the exchange. The listing department of the NSE has recorded the reference number NSE/LIST/2026/55966 for this transaction.

Historical Stock Returns for Banka Bioloo

1 Day5 Days1 Month6 Months1 Year5 Years
-1.86%-2.07%-0.33%+43.69%+28.52%+41.00%

How will the increased liquidity from these 9,500 shares impact Banka Bioloo's stock volatility in the short term?

Does this ESOP allotment signal an upcoming expansion of the company's workforce or a retention strategy for key personnel?

What are the company's future plans regarding further ESOP issuances to align employee interests with shareholder value?

More News on Banka Bioloo

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+28.52%